Customized research for ABUS vs. RYTM!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for ABUS vs. RYTM.


↗ Join Our Free Email Newsletter.




Arbutus Biopharma Corporation vs. Rhythm Pharmaceuticals Inc.

Industry Match! Industry of Both ABUS and RYTM:

Health Care/Life Sciences

ABUS
Data Last Updated: More than a wk ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 94.94M


P/E: N/A

P/S: 15.96

Q P/B: 1.14

Y Rev: 5.95M

Q Rev: 3.06M

Beta: 1.74

ABUS Share Stats

Outstanding Shares

56.85M

Float Shares

37.21M

Percent of Float Short

1.94%

ABUS Insider Stats

Percent Outstanding Insider Ownership

10.74%

Percent Outstanding Institution Ownership

38.07%

ABUS Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ABUS in Pulse Portal

Stream of Posts

ABUS Symbol Page

Share ABUS Insights

Express Sentiment

'Buy' or 'Sell' ABUS

ABUS Profile

CEO

Dr. Frank Torti

Exchange

Nasdaq

Employees

80.00

About

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, Canada.

ABUS Financials

Annual Financials

Income Statement

Revenue

5.95M

Net Income

(57.06M)

Cash Flow Statement

Change in Cash / Investments

(17.35M)

Balance Sheet

Cash / Investments

124.62M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

129.23M

Total Current Liabilities

11.24M

Total Assets

227.91M

Total Liabilities

27.67M

Stockholder Equity

200.23M

Quarterly Financials

Income Statement

Q Revenue

3.06M

Q Net Income

(82.5M)

Cash Flow Statement

Q Change in Cash / Investments

11.74M

Balance Sheet

Q Cash / Investments

90.08M

Q Short Term Debt

329,000

Q Long Term Debt

None

Q Total Current Assets

94.34M

Q Total Current Liabilities

8.82M

Q Total Assets

117.28M

Q Total Liabilities

33.64M

Q Stockholder Equity

83.64M

ABUS Charts

10-Year Chart

ABUS 10-Year Chart

5-Year Chart

ABUS 5-Year Chart

1-Year Chart

ABUS 1-Year Chart

6-Month Chart

ABUS 6-Month Chart

3-Month Chart

ABUS 3-Month Chart

1-Month Chart

ABUS 1-Month Chart

1-Day Chart

ABUS 1-Day Chart

RYTM
Data Last Updated: 18 hours ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 1.1B


P/E: N/A

P/S: N/A

Q P/B: 7.38

Y Rev: -

Q Rev: -

Beta: 0.64

RYTM Share Stats

Outstanding Shares

34.52M

Float Shares

24.96M

Percent of Float Short

10.50%

RYTM Insider Stats

Percent Outstanding Insider Ownership

1.9%

Percent Outstanding Institution Ownership

98.64%

RYTM Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

RYTM in Pulse Portal

Stream of Posts

RYTM Symbol Page

Share RYTM Insights

Express Sentiment

'Buy' or 'Sell' RYTM

RYTM Profile

CEO

Dr. Keith M. Gottesdiener

Exchange

Nasdaq

Employees

54.00

About

Rhythm Pharmaceuticals, Inc. develops and commercializes peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. It focuses on the treatment for Prader-Willi Syndrome and Pro-Opiomelanocortin deficiency obesity. The firm rapidly...

RYTM Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(74.06M)

Cash Flow Statement

Change in Cash / Investments

15.48M

Balance Sheet

Cash / Investments

252.06M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

258.69M

Total Current Liabilities

13.58M

Total Assets

260.21M

Total Liabilities

13.95M

Stockholder Equity

246.26M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(36M)

Cash Flow Statement

Q Change in Cash / Investments

8.56M

Balance Sheet

Q Cash / Investments

162.44M

Q Short Term Debt

457,000

Q Long Term Debt

None

Q Total Current Assets

170.88M

Q Total Current Liabilities

25.21M

Q Total Assets

177.53M

Q Total Liabilities

28.42M

Q Stockholder Equity

149.12M

RYTM Charts

10-Year Chart

RYTM 10-Year Chart

5-Year Chart

RYTM 5-Year Chart

1-Year Chart

RYTM 1-Year Chart

6-Month Chart

RYTM 6-Month Chart

3-Month Chart

RYTM 3-Month Chart

1-Month Chart

RYTM 1-Month Chart

1-Day Chart

RYTM 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon